+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)
New

Rabies Infection Epidemiology Forecast 2025-2034

  • PDF Icon

    Report

  • 150 Pages
  • June 2025
  • Region: Global
  • Expert Market Research
  • ID: 6102507
Rabies infection is reported to kill 70,000 people worldwide every year, with dogs responsible for 99% of human rabies deaths outside the United States. Studies show that children between the ages of 5 and 14 years are frequently the victims of this viral disease.

Rabies Infection Epidemiology Forecast Report Coverage

The “Rabies Infection Epidemiology Forecast Report 2025-2034” offers comprehensive information on the prevalence and demographics of rabies infection. It projects the future incidence and prevalence rates of rabies infection across various populations. The study covers age, gender, and type as major determinants of the rabies infection-affected population. The report highlights patterns in the prevalence of rabies infection over time and projects future trends based on multiple variables.

The report provides a comprehensive overview of the disease, as well as historical and projected data on the epidemiology of Rabies Infection in the 8 major markets.

Regions Covered

  • The United States
  • Germany
  • France
  • Italy
  • Spain
  • The United Kingdom
  • Japan
  • India

Rabies Infection Disease Overview

Rabies is a zoonotic, viral disease that affects the central nervous system. It is transmitted through the saliva of infected animals and can be prevented by a vaccine. Rabies infects mammals such as dogs, livestock, cats, and wildlife. The viral infection leads to progressive and fatal inflammation of the spinal cord and brain. Common symptoms include hydrophobia, fever, headache, muscle spasms, phonophobia, paralysis, hallucinations, and mental confusion, among others.

Rabies Infection: Treatment Overview

A preventive vaccine, typically given in 5 doses for a duration of 28 days, is used if there is any risk of rabies. Human rabies immunoglobulin (HRIG) treatment is given to the patient on the day the bite occurred. Once the symptoms appear, the survival of the infected individual is rare, even after treatment. Death from respiratory failure generally happens within 7 days after the onset of symptoms. It is recommended to receive a vaccination if an individual is frequently exposed to a high-risk occupation or traveling to countries with a high prevalence of rabies.

Epidemiology

The rabies infection epidemiology section offers information on the patient pool from history to the present as well as the projected trend for each of the 8 major markets. The publisher provides both current and predicted trends for rabies infection by examining a wide range of studies. Additionally, the report covers the diagnosed patient pool for rabies infection and their trends. The data is broken down into specific categories, such as total prevalent cases in males and females, and total diagnosed cases across different age groups and patient pools.
  • Rabies is considered a serious health issue in more than 150 countries and territories, predominantly in Africa and Asia. This neglected tropical disease leads to tens of thousands of deaths every year, with about 40% of the affected population being children below 15 years of age.
  • Approximately 99% of human rabies cases are a result of dog bites and scratches, according to the World Health Organization (WHO).
  • As per the Centers for Disease Control and Prevention (CDC), rabies is responsible for 70,000 deaths every year, despite being 100% preventable.
  • Studies show that encephalitic or furious rabies accounts for 85% of human cases, with hyperactivity and hydrophobia being the dominant symptoms.

Country-wise Rabies Infection Epidemiology

The rabies infection epidemiology data and findings for the United States, EU-4 (Germany, Spain, Italy, France), the United Kingdom, Japan, and India are also provided in the epidemiology section.

The epidemiology of rabies infection varies between countries owing to differences in animal control, vaccination programs, healthcare access, and public awareness. Around 36% of the global deaths due to rabies occur in India, as per the World Health Organization (WHO). Further, India covers 65% of the deaths due to rabies in the South-East Asia region.

Scope of the Report

  • The report covers a detailed analysis of signs and symptoms, causes, risk factors, pathophysiology, diagnosis, treatment options, and classification/types of rabies infection based on several factors.
  • Rabies Infection Epidemiology Forecast Report covers data for the eight major markets (the US, France, Germany, Italy, Spain, the UK, Japan, and India).
  • The report helps to identify the patient population and the unmet needs of rabies infection are highlighted along with an assessment of the disease's risk and burden.

Key Questions Answered

  • What are the key findings of rabies infection epidemiology in the 8 major markets?
  • What will be the total number of patients with rabies infection across the 8 major markets during the forecast period?
  • What was the country-wise prevalence of rabies infection in the 8 major markets in the historical period?
  • Which country will have the highest number of rabies infection patients during the forecast period of 2025-2034?
  • Which key factors would influence the shift in the patient population of rabies infection during the forecast period of 2025-2034?
  • What are the currently available treatments for rabies infection?
  • What are the disease risks, signs, symptoms, and unmet needs of rabies infection?

This product will be delivered within 3-5 business days.

Table of Contents

1 Preface
1.1 Introduction
1.2 Objectives of the Study
1.3 Research Methodology and Assumptions
2 Executive Summary
3 Rabies Infection Market Overview - 8 MM
3.1 Rabies Infection Market Historical Value (2018-2024)
3.2 Rabies Infection Market Forecast Value (2025-2034)
4 Rabies Infection Epidemiology Overview - 8 MM
4.1 Rabies Infection Epidemiology Scenario (2018-2024)
4.2 Rabies Infection Epidemiology Forecast (2025-2034)
5 Disease Overview
5.1 Signs and Symptoms
5.2 Causes
5.3 Risk Factors
5.4 Guidelines and Stages
5.5 Pathophysiology
5.6 Screening and Diagnosis
5.7 Types of Rabies Infection
6 Patient Profile
6.1 Patient Profile Overview
6.2 Patient Psychology and Emotional Impact Factors
7 Epidemiology Scenario and Forecast - 8 MM (218-2034)
7.1 Key Findings
7.2 Assumptions and Rationale
7.3 Diagnosed Prevalent Cases of Rabies Infection
7.4 Type-Specific Cases of Rabies Infection
7.5 Gender-Specific Cases of Rabies Infection
7.6 Age-Specific Cases of Rabies Infection
8 Epidemiology Scenario and Forecast: United States (218-2034)
8.1 Assumptions and Rationale in the United States
8.2 Diagnosed Prevalent Cases of Rabies Infection in the United States
8.3 Type-Specific Cases of Rabies Infection in the United States
8.4 Gender-Specific Cases of Rabies Infection in the United States
8.5 Age-Specific Cases of Rabies Infection in the United States
9 Epidemiology Scenario and Forecast: United Kingdom (218-2034)
9.1 Assumptions and Rationale in the United Kingdom
9.2 Diagnosed Prevalent Cases of Rabies Infection in the United Kingdom
9.3 Type-Specific Cases of Rabies Infection in the United Kingdom
9.4 Gender-Specific Cases of Rabies Infection in the United Kingdom
9.5 Age-Specific Cases of Rabies Infection in the United Kingdom
10 Epidemiology Scenario and Forecast: Germany (218-2034)
10.1 Assumptions and Rationale in Germany
10.2 Diagnosed Prevalent Cases of Rabies Infection in Germany
10.3 Type-Specific Cases of Rabies Infection in Germany
10.4 Gender-Specific Cases of Rabies Infection in Germany
10.5 Age-Specific Cases of Rabies Infection in Germany
11 Epidemiology Scenario and Forecast: France (218-2034)
11.1 Assumptions and Rationale in France
11.2 Diagnosed Prevalent Cases of Rabies Infection in France
11.3 Type-Specific Cases of Rabies Infection in France
11.4 Gender-Specific Cases of Rabies Infection in France
11.5 Age-Specific Cases of Rabies Infection in France
12 Epidemiology Scenario and Forecast: Italy (218-2034)
12.1 Assumptions and Rationale in Italy
12.2 Diagnosed Prevalent Cases of Rabies Infection in Italy
12.3 Type-Specific Cases of Rabies Infection in Italy
12.4 Gender-Specific Cases of Rabies Infection in Italy
12.5 Age-Specific Cases of Rabies Infection in Italy
13 Epidemiology Scenario and Forecast: Spain (218-2034)
13.1 Assumptions and Rationale in Spain
13.2 Diagnosed Prevalent Cases of Rabies Infection in Spain
13.3 Type-Specific Cases of Rabies Infection in Spain
13.4 Gender-Specific Cases of Rabies Infection in Spain
13.5 Age-Specific Cases of Rabies Infection in Spain
14 Epidemiology Scenario and Forecast: Japan (218-2034)
14.1 Assumptions and Rationale in Japan
14.2 Diagnosed Prevalent Cases of Rabies Infection in Japan
14.3 Type-Specific Cases of Rabies Infection in Japan
14.4 Gender-Specific Cases of Rabies Infection in Japan
14.5 Age-Specific Cases of Rabies Infection in Japan
15 Epidemiology Scenario and Forecast: India (218-2034)
15.1 Assumptions and Rationale in India
15.2 Diagnosed Prevalent Cases of Rabies Infection in India
15.3 Type-Specific Cases of Rabies Infection in India
15.4 Gender-Specific Cases of Rabies Infection in India
15.5 Age-Specific Cases of Rabies Infection in India
16 Patient Journey17 Treatment Challenges and Unmet Needs18 Key Opinion Leaders (KOL) Insights